Segall Bryant & Hamill’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,757
Closed -$4.34M 630
2026
Q1
$4.34M Sell
17,757
-25
-0.1% -$5.82K 0.06% 319
2025
Q4
$3.68M Sell
17,782
-17,911
-50% -$3.54M 0.05% 352
2025
Q3
$6.62M Sell
35,693
-409
-1% -$70.1K 0.09% 288
2025
Q2
$5.51M Sell
36,102
-301
-0.8% -$46.3K 0.08% 305
2025
Q1
$6.04M Sell
36,403
-267
-0.7% -$41.8K 0.09% 282
2024
Q4
$5.3M Buy
36,670
+367
+1% +$56.9K 0.07% 322
2024
Q3
$5.88M Buy
+36,303
New +$5.78M 0.08% 306
2023
Q4
Sell
-279,599
Closed -$43.5M 404
2023
Q3
$43.5M Sell
279,599
-20,691
-7% -$3.41M 0.5% 58
2023
Q2
$49.7M Sell
300,290
-5,461
-2% -$881K 0.52% 50
2023
Q1
$47.4M Buy
305,751
+454
+0.1% +$73.3K 0.51% 51
2022
Q4
$53.9M Buy
305,297
+2,628
+0.9% +$454K 0.6% 43
2022
Q3
$49.4M Sell
302,669
-761
-0.3% -$129K 0.59% 47
2022
Q2
$53.9M Sell
303,430
-6,503
-2% -$1.16M 0.61% 44
2022
Q1
$54.9M Sell
309,933
-11,354
-4% -$1.93M 0.53% 48
2021
Q4
$55M Sell
321,287
-4,259
-1% -$697K 0.51% 53
2021
Q3
$52.5M Buy
325,546
+6,102
+2% +$1.04M 0.5% 49
2021
Q2
$52.6M Sell
319,444
-10,674
-3% -$1.77M 0.51% 50
2021
Q1
$54.2M Sell
330,118
-8,432
-2% -$1.36M 0.54% 48
2020
Q4
$53.3M Sell
338,550
-4,876
-1% -$720K 0.59% 44
2020
Q3
$51.1M Buy
343,426
+11,512
+3% +$1.7M 0.69% 38
2020
Q2
$46.7M Sell
331,914
-16,015
-5% -$2.33M 0.78% 33
2020
Q1
$45.6M Sell
347,929
-9,472
-3% -$1.34M 0.93% 24
2019
Q4
$52.2M Sell
357,401
-31,595
-8% -$4.29M 0.81% 30
2019
Q3
$50.3M Sell
388,996
-10,302
-3% -$1.36M 0.78% 26
2019
Q2
$55.6M Sell
399,298
-106,976
-21% -$14.8M 0.84% 23
2019
Q1
$70.8M Buy
506,274
+12,795
+3% +$1.71M 1.1% 13
2018
Q4
$63.7M Buy
493,479
+28,245
+6% +$3.94M 1.1% 11
2018
Q3
$64.3M Sell
465,234
-9,011
-2% -$1.2M 0.95% 11
2018
Q2
$57.5M Buy
474,245
+52,476
+12% +$6.55M 0.88% 16
2018
Q1
$54M Sell
421,769
-21,402
-5% -$2.89M 1.25% 15
2017
Q4
$61.9M Sell
443,171
-12,348
-3% -$1.72M 1.36% 11
2017
Q3
$59.2M Sell
455,519
-30
-0% -$3.98K 1.38% 8
2017
Q2
$60.3M Buy
455,549
+109
+0% +$13.9K 1.42% 10
2017
Q1
$56.7M Buy
455,440
+9,721
+2% +$1.16M 1.37% 10
2016
Q4
$51.4M Buy
445,719
+44,521
+11% +$5.14M 1.29% 11
2016
Q3
$47.4M Buy
401,198
+22,699
+6% +$2.75M 1.22% 14
2016
Q2
$45.9M Sell
378,499
-1,553
-0.4% -$176K 1.21% 12
2016
Q1
$41.1M Buy
380,052
+5,820
+2% +$603K 1.02% 18
2015
Q4
$38.4M Sell
374,232
-2,276
-0.6% -$229K 0.92% 20
2015
Q3
$35.1M Buy
376,508
+55,573
+17% +$5.38M 0.86% 25
2015
Q2
$31.3M Sell
320,935
-953
-0.3% -$95.4K 0.7% 37
2015
Q1
$32.4M Sell
321,888
-5,549
-2% -$564K 0.73% 34
2014
Q4
$34.2M Sell
327,437
-16,682
-5% -$1.76M 0.77% 29
2014
Q3
$36.7M Buy
344,119
+5,203
+2% +$540K 0.85% 24
2014
Q2
$35.5M Buy
338,916
+77,720
+30% +$7.86M 0.84% 21
2014
Q1
$25.7M Sell
261,196
-33,619
-11% -$3.12M 0.61% 43
2013
Q4
$27M Sell
294,815
-854
-0.3% -$78.7K 0.63% 51
2013
Q3
$25.6M Sell
295,669
-2,152
-0.7% -$193K 0.63% 47
2013
Q2
$25.6M Buy
+297,821
New +$25.3M 0.67% 42

Other funds holding JNJ

Segall Bryant & Hamill's JNJ Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 17,757 shares — an estimated $4.34M sold.

Segall Bryant & Hamill first reported a position in JNJ in Q2 2013 and held it in 49 quarters. The position peaked at $70.8M in Q1 2019. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Segall Bryant & Hamill reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 17,757 Johnson & Johnson shares in Q2 2026, an estimated $4.34M.
  • Segall Bryant & Hamill first reported a position in Johnson & Johnson in Q2 2013 and held it in 49 quarters.
  • Segall Bryant & Hamill's Johnson & Johnson position peaked at $70.8M in Q1 2019.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.